Video Experimental Relacionado
Updated: Aug 10, 2026

10:32
Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination
Published on: August 24, 2015
Riesgo de transfusión de plaquetas en la púrpura trombótica trombocitopénica
JAMA
|October 23, 1981
Resumen
Las transfusiones de plaquetas pueden empeorar la púrpura trombótica trombocitopénica (TTP) al causar una peligrosa agregación plaquetaria en el cerebro. Este estudio sugiere que la agregación plaquetaria inicial es clave en la patogénesis de la TTP.
Área de la Ciencia:
- Hematología Hematología.
- Patología Patología Patología.
- Neurología Neurología.
Sus antecedentes:
- La púrpura trombótica trombocitopénica (TTP) es un trastorno de la sangre poco frecuente.
- La participación del sistema nervioso central (SNC) en la TTP puede ser grave.
- Se debate el papel de la transfusión de plaquetas en la TTP.
Objetivo del estudio:
- Investigar el papel potencial de la agregación plaquetaria en la TTP.
- Para examinar los efectos de la transfusión de plaquetas en un paciente TTP con afectación del SNC.
- Para identificar los mecanismos subyacentes de la exacerbación de la TTP.
Principales métodos:
- Estudio de caso de un paciente TTP con síntomas severos del SNC después de la infusión de plaquetas.
- Examen postmortem del cerebro y otros tejidos.
- Análisis del plasma para la actividad de agregación plaquetaria.
Principales resultados:
- El paciente exhibió síntomas catastróficos del SNC inmediatamente después de la infusión de plaquetas.
- Los hallazgos postmortem revelaron extensos agregados de plaquetas en pequeños vasos cerebrales.
- Las lesiones en otros órganos mostraron depósitos de fibrina plaquetaria, proliferación endotelial y microaneurismas.
- El plasma del paciente contenía actividad de agregación plaquetaria.
Conclusiones:
- La agregación plaquetaria puede ser el evento inicial en TTP.
- Las transfusiones de plaquetas pueden potencialmente agravar la TTP al exacerbar la agregación plaquetaria.
- Los hallazgos sugieren precaución con respecto a las transfusiones de plaquetas en pacientes con TTP.
Videos de Conceptos Relacionados
Blood Transfusion and Agglutination
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Structure and Function of Platelets
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

